ArticleACS omega2026
An Eco-Friendly Disposable Plasmonic Biochip Based on Bacterial Cellulose for Interleukin-17A Detection at Atto-Femto Molar Level.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The need for disposable, low-cost, biodegradable, small-size, and biocompatible sensor chips is crucial for the development of point-of-care tests (POCTs) in several bio/chemical sensing application fields. In this scenario, an eco-friendly sensor chip based on gold-coated bacterial cellulose (BC) nanostructures, which exploits localized surface plasmon resonance (LSPR) phenomena, is combined with a bioreceptor layer as a proof-of-concept for cytokine detection. The BC-based LSPR chip was developed and tested using a simple transmission-based experimental setup, enabling both bulk and binding sensitivity characterization. In particular, the optical analysis revealed a BC-based LSPR chip's bulk sensitivity of about 370 nm/RIU, comparable to that of more complex and expensive LSPR platforms reported in the literature. Following a functionalization process with an antibody specific for the interleukin 17A (IL-17A) protein, the BC-based LSPR biochip was tested, demonstrating an ultralow detection limit in the atto-femto molar range (detection limit of approximately 400 aM), an ultrawide detection range, and good selectivity toward other interleukins, making it a proof-of-principle useful in biomedical applications. The achieved results paved the way for the applicability of this eco-friendly biochip as a disposable chip useful for POCTs in several application fields, where the required disposable feature is due to contamination that occurs during measurements in real-world scenarios.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.